Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials.
The Canadian journal of cardiology(2023)
摘要
Aggregate evidence on the basis of placebo comparisons from randomized trials supports the potential for oral factor Xa inhibitors to reduce ischemic stroke in patients without AF, but major bleeding is increased.
更多查看译文
关键词
apixaban,betrixaban,factor Xa inhibitors,intracranial bleeding,ischemic stroke,major bleeding,rivaroxaban,stroke
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要